These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38840308)

  • 1. Critically appraised topic: the use of vaccination to control the spread of foot-and-mouth disease in Australian livestock in the event of an incursion.
    Humphries B; Ward MP
    Aust Vet J; 2024 Aug; 102(8):407-415. PubMed ID: 38840308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic benefits of targeted response strategies against foot-and-mouth disease in Australia.
    Seitzinger AH; Hafi A; Addai D; Garner G; Bradhurst R; Breed AC; Capon T; Miller C; Pinol J; Tapsuwan S
    Prev Vet Med; 2022 Jul; 204():105636. PubMed ID: 35430444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing control strategies against foot-and-mouth disease: will vaccination be cost-effective in Denmark?
    Boklund A; Halasa T; Christiansen LE; Enøe C
    Prev Vet Med; 2013 Sep; 111(3-4):206-19. PubMed ID: 23791121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating vaccination strategies to control foot-and-mouth disease: a country comparison study.
    Rawdon TG; Garner MG; Sanson RL; Stevenson MA; Cook C; Birch C; Roche SE; Patyk KA; Forde-Folle KN; Dubé C; Smylie T; Yu ZD
    Epidemiol Infect; 2018 Jul; 146(9):1138-1150. PubMed ID: 29785893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FMD vaccine allocation and surveillance resourcing options for a potential Australian incursion.
    Seitzinger AH; Garner MG; Bradhurst R; Roche S; Breed AC; Capon T; Miller C; Tapsuwan S
    Aust Vet J; 2022 Nov; 100(11):550-561. PubMed ID: 36106431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic benefits of implementing trading zones for Australian livestock disease outbreaks of limited duration.
    Hafi A; Addai D; Breed AC; Bradhurst R; Capon T; Garner MG; Miller C; Pinol J; Seitzinger AH; Tapsuwan S
    Aust Vet J; 2022 Apr; 100(4):150-161. PubMed ID: 35049045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the impact of vaccination control strategies on a foot and mouth disease outbreak in the Central United States.
    McReynolds SW; Sanderson MW; Reeves A; Hill AE
    Prev Vet Med; 2014 Dec; 117(3-4):487-504. PubMed ID: 25457133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggers for foot and mouth disease vaccination in the United States.
    Parent KB; Miller GY; Hullinger PJ
    Rev Sci Tech; 2011 Dec; 30(3):789-96. PubMed ID: 22435191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do resources influence control measures during a simulated outbreak of foot and mouth disease in Australia?
    Roche SE; Garner MG; Wicks RM; East IJ; de Witte K
    Prev Vet Med; 2014 Mar; 113(4):436-46. PubMed ID: 24412502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-benefit analysis of Vietnam's 2006-2010 foot-and-mouth disease control program.
    Do H; Nguyen HT; Van Ha P; Dang Van K
    Prev Vet Med; 2022 Sep; 206():105703. PubMed ID: 35797822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against foot-and-mouth disease: the implications for Canada.
    Kahn S; Geale DW; Kitching PR; Bouffard A; Allard DG; Duncan JR
    Can Vet J; 2002 May; 43(5):349-54. PubMed ID: 12001500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of FMD virus.
    Donaldson AI
    Vet Rec; 2006 Apr; 158(16):571-2. PubMed ID: 16632535
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against foot-and-mouth disease I: epidemiological consequences.
    Backer JA; Hagenaars TJ; Nodelijk G; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):27-40. PubMed ID: 22749763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the spread of foot-and-mouth disease in Australia.
    Garner MG; Beckett SD
    Aust Vet J; 2005 Dec; 83(12):758-66. PubMed ID: 16395942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating vaccination strategies to control foot-and-mouth disease: a model comparison study.
    Roche SE; Garner MG; Sanson RL; Cook C; Birch C; Backer JA; Dube C; Patyk KA; Stevenson MA; Yu ZD; Rawdon TG; Gauntlett F
    Epidemiol Infect; 2015 Apr; 143(6):1256-75. PubMed ID: 25078780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the field personnel resources to control foot-and-mouth disease outbreaks in New Zealand.
    Sanson RL; Rawdon TG; van Andel M; Yu Z
    Transbound Emerg Dis; 2022 Nov; 69(6):3926-3939. PubMed ID: 36397293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the benefit of emergency vaccination in a foot-and-mouth disease free country with low livestock density.
    Dürr S; Fasel-Clemenz C; Thür B; Schwermer H; Doherr MG; Dohna HZ; Carpenter TE; Perler L; Hadorn DC
    Prev Vet Med; 2014 Jan; 113(1):34-46. PubMed ID: 24211105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact.
    Barasa M; Catley A; Machuchu D; Laqua H; Puot E; Tap Kot D; Ikiror D
    Transbound Emerg Dis; 2008 Oct; 55(8):339-51. PubMed ID: 18786073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit and feasibility analysis for establishing a foot-and-mouth disease free zone in Rukwa region in Tanzania.
    Häsler B; Limon G; Queenan K; Rushton J; Madege M; Mlangwa J; Mghwira J
    Prev Vet Med; 2021 Nov; 196():105494. PubMed ID: 34656049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.